31 results on '"Novartis Pharma AG -- Reports"'
Search Results
2. Reports from Novartis Pharmaceuticals AG Add New Study Findings to Research in Inflammatory Bowel Disease (Adenosine-mediated immune responses in inflammatory bowel disease)
3. New Findings in Chronic Myeloid Leukemia Described from University Clinic (Asciminib In Newly Diagnosed Chronic Myeloid Leukemia)
4. Reports from Novartis Pharmaceuticals AG Highlight Recent Findings in Obesity, Fitness and Wellness (Rescoss: a Flexible Quantum Chemistry Workflow Identifying Relevant Solution Conformers of Drug-like Molecules)
5. Study Findings on Alzheimer Disease Are Outlined in Reports from Novartis Pharmaceuticals AG [Discovery of Umibecestat (Cnp520): a Potent, Selective, and Efficacious Beta-secretase (Bace1) Inhibitor for the Prevention of Alzheimer's Disease]
6. Novartis Pharmaceuticals AG Researchers Release New Study Findings on Pharmaceutics (Tablet formulation development focusing on the functional behaviour of water uptake and swelling)
7. Studies from Novartis Pharmaceuticals AG Describe New Findings in Pharmaceutical Research (Single-crystal Drying: Development of a Continuous Drying Prototype To Optimize Particle Flow and Residence Time Distribution)
8. Researchers' Work from Novartis Pharmaceuticals AG Focuses on Personalized Medicine (Using Knockoffs for Controlled Predictive Biomarker Identification)
9. New Data from Novartis Pharmaceuticals K.K. Illuminate Findings in Soft Tissue Sarcomas (Postmarketing observational study of pazopanib in patients with metastatic soft tissue sarcoma in Japan)
10. Studies from Novartis Pharmaceuticals AG Add New Findings in the Area of Organic Research (A General Kilogram Scale Protocol for Suzuki-miyaura Cross-coupling In Water With Tpgs-750-m Surfactant)
11. New Findings Reported from Novartis Pharmaceuticals AG Describe Advances in Steroid Receptors [Synthesis Development of the Selective Estrogen Receptor Degrader (Serd) Lsz102 From a Suzuki Coupling To a C-h Activation Strategy]
12. New Findings from Novartis Pharmaceuticals AG Yields New Data on Clinical Pharmacology (Reporting rates of adverse reactions to specialty care medicines exhibit a direct positive correlation with patient exposure: a lack of evidence for the ...)
13. New Heart Failure Study Findings Have Been Reported by Investigators at Georg-August-University (Serelaxin Alleviates Cardiac Fibrosis Through Inhibiting Endothelial-to-mesenchymal Transition Via Rxfp1)
14. Researchers from Novartis Pharmaceuticals Report on Findings in Pharmaceutical Research (Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying)
15. Studies in the Area of Heart Failure Reported from University of Southern California [Patient Commitment to Health (PACT-Health) in the Heart Failure Population: A Focus Group Study of an Active Communication Framework for Patient-Centered ...]
16. Study Results from Novartis in the Area of Chemistry Reported (Derivation of Rapamycin: Adventures in Natural Product Chemistry)
17. Recent Findings from Novartis Pharma AG Provides New Insights into Biosimilars (The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective On Current Practice and a Proposal)
18. Researchers at Kumamoto University Report New Data on Cancer (A Retrospective Study of Arterial Stiffness and Subsequent Clinical Outcomes In Cancer Patients Undergoing Percutaneous Coronary Intervention)
19. Recent Findings in Vasculitis Described by Researchers from University of Liverpool (Vasculitis In Juvenile-onset Systemic Lupus Erythematosus)
20. New Non-Small Cell Lung Cancer Data Have Been Reported by Researchers at University of Duisburg-Essen (Impact of Ras Mutation Subtype On Clinical Outcome-a Cross-entity Comparison of Patients With Advanced Non-small Cell Lung Cancer and ...)
21. Findings from ICON plc Provides New Data about Information Technology (Identification and mapping of worldwide sources of generic real-world data)
22. New Antifungals Study Results from Novartis Described (CYP3A but not P-gp plays a relevant role in the in vivo intestinal and hepatic clearance of the delta-specific phosphoinositide-3 kinase inhibitor leniolisib)
23. New Drug Safety Findings from Kyoto University Discussed (Potentially Inappropriate Medication Prescribing and Risk of Unplanned Hospitalization among the Elderly: A Self-Matched, Case-Crossover Study)
24. Researchers from Royal Brisbane Hospital Detail New Studies and Findings in the Area of Neuroendocrine Cancer (Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours)
25. New Findings on Pharmaceutical Science Described by Investigators at Novartis (Protein Adsorption to In-Line Filters of Intravenous Administration Sets)
26. Findings in Heart Failure Reported from Department of Internal Medicine (Treatment of chronic heart failure in Germany: a retrospective database study)
27. New Findings from University of Melbourne Describe Advances in Epilepsy (Frequency of CNKSR2 mutation in the X-linked epilepsy-aphasia spectrum)
28. New Pharmacokinetics Findings from Novartis Pharma Described (Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy)
29. New Experimental Pharmacology Study Findings Have Been Reported by Researchers at Novartis Pharma (Trends in Modern Drug Discovery)
30. Reports Outline Pharmaceutical Research Study Results from Novartis Pharma (Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice)
31. Studies from Novartis Pharma Add New Findings in the Area of Squamous Cell Carcinoma (Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous ...)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.